CBGL Stock Overview
Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cannabis Global, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0004 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 9,900.00% |
| 1 Year Change | -50.00% |
| 33 Year Change | -98.78% |
| 5 Year Change | -99.98% |
| Change since IPO | -93.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBGL | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.6% | 0.5% |
| 1Y | -50.0% | 13.1% | 30.7% |
Return vs Industry: CBGL underperformed the US Pharmaceuticals industry which returned 14.2% over the past year.
Return vs Market: CBGL underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| CBGL volatility | |
|---|---|
| CBGL Average Weekly Movement | 10,310.2% |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CBGL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CBGL's weekly volatility has increased from 6965% to 10310% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Eddie Manolos | www.cannabisglobalinc.com |
Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. The company offers cannabis flower packaged, pre-rolls, and edible products to cannabis retailers and distributors; and Comply Bag, a solution for cannabis storage, transport, and tracking. It also provides managerial services in areas of the regulated hemp and cannabis industries.
Cannabis Global, Inc. Fundamentals Summary
| CBGL fundamental statistics | |
|---|---|
| Market cap | US$453.43k |
| Earnings (TTM) | -US$13.85m |
| Revenue (TTM) | US$1.06m |
0.0x
P/S Ratio0.0x
P/E RatioIs CBGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBGL income statement (TTM) | |
|---|---|
| Revenue | US$1.06m |
| Cost of Revenue | US$1.17m |
| Gross Profit | -US$115.44k |
| Other Expenses | US$13.73m |
| Earnings | -US$13.85m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CBGL perform over the long term?
See historical performance and comparison